Does MyRisk determine cancer stage?

Does MyRisk determine cancer stage?

• A. No
• B. Yes
• C. It determines stage by imaging
• D. It determines stage by biopsy

Answer: (A)

Staging reflects how far cancer has spread and is determined after a diagnosis by evaluating the tumor, nearby lymph nodes, and distant sites. This relies on imaging studies (like CT, MRI, or PET-CT) and pathology from biopsy or surgical specimens to assign a stage. MyRisk is a hereditary cancer risk assessment tool that uses family history and personal cancer history to estimate the likelihood of carrying a pathogenic germline variant and to guide genetic testing and risk-reduction strategies. It does not assess tumor characteristics or disease extent, so it does not determine cancer stage.

Staging reflects how far cancer has spread and is determined after a diagnosis by evaluating the tumor, nearby lymph nodes, and distant sites. This relies on imaging studies (like CT, MRI, or PET-CT) and pathology from biopsy or surgical specimens to assign a stage. MyRisk is a hereditary cancer risk assessment tool that uses family history and personal cancer history to estimate the likelihood of carrying a pathogenic germline variant and to guide genetic testing and risk-reduction strategies. It does not assess tumor characteristics or disease extent, so it does not determine cancer stage.